Restricted Access

Before you enter

All products are sold strictly for in-vitro laboratory research โ€” not for human consumption, therapeutic, or veterinary use.

Your confirmation is saved for 7 days. You will only be asked to confirm once per week.
By entering you accept full responsibility for compliance with all applicable laws.

โš ๏ธย  RESEARCH PURPOSES ONLY โ€” This compound is not FDA authorized for human consumption. All referenced data is presented for informational and educational purposes only.

bpctb10

BPC-157/TB-500 10MG

Wolverine BlendBPC + TB4Regenerative Peptide StackBody Protection Compound + Thymosin Beta-4
A synergistic peptide combination designed to support tissue repair and regenerative processes through complementary cellular mechanisms in animal research models.

$100.00

Quantity
Free shippingon orders over $150
Damageprotection
Secure checkout256-bit SSL
๐Ÿ”„
2
Synergistic Pathways
VEGF + Actin regulation
๐Ÿ“ˆ
370+
Combined Studies
BPC-157 (200+) + TB-500 (170+)
โšก
61%
Faster Healing
TB-500 re-epithelialization
โœ…
99%+
Purity Verified
HPLC tested, COA included

How It Works

Dual-peptide blend targeting complementary tissue repair pathways

BPC-157

Angiogenesis & Cytoprotection

BPC-157 upregulates VEGF expression and promotes new blood vessel formation, delivering nutrients and oxygen to damaged tissue. It also activates the NO system and demonstrates broad cytoprotective properties.

  • VEGF-mediated angiogenesis
  • Nitric oxide system modulation
  • Gastric and tissue cytoprotection
TB-500

Cell Migration & Actin Regulation

TB-500 sequesters G-actin monomers and promotes cytoskeletal remodeling, enabling repair cells to migrate to injury sites. It also activates integrin-linked kinase (ILK) for tissue repair signaling.

  • Actin-mediated cell migration
  • Integrin-linked kinase activation
  • Anti-fibrotic remodeling
Synergy

Complementary Repair Cascade

BPC-157 initiates vascular support (blood flow to injury), while TB-500 mobilizes repair cells to the site. Together they address two distinct phases of tissue repair โ€” perfusion and cellular migration.

  • Phase 1: Blood flow restoration (BPC-157)
  • Phase 2: Cell mobilization (TB-500)
  • Combined anti-inflammatory effects
๐Ÿ“Š

What Research Has Shown

Key preclinical findings from individual component studies

BPC-157 Tendon Healing 72%
TB-500 Cell Migration 85%
BPC-157 GHR Expression 700%
TB-500 Wound Closure 61%
๐ŸŽฏ

Research Applications

Primary areas of investigation

MUSCULOSKELETAL

Tendon & Ligament

BPC-157 accelerates tendon healing while TB-500 enhances cell migration to the injury site for coordinated soft tissue repair.

Chang et al. 2014 โ†—
DERMATOLOGY

Wound Healing

TB-500 promotes dermal healing and reduces scarring; BPC-157 provides vascular support for nutrient delivery to wound sites.

Malinda et al. 2007 โ†—
CARDIOVASCULAR

Vascular Repair

BPC-157 promotes angiogenesis via the NO system while TB-500 supports cardiac cell migration through ILK activation.

Sikiric et al. 2019 โ†—
ANTI-INFLAMMATORY

Inflammation Control

Both peptides demonstrate anti-inflammatory properties through distinct mechanisms, creating a more controlled healing environment.

Sikiric et al. 2011 โ†—
๐Ÿงช

Compound Information

Technical specifications

Chemical Name BPC-157 + TB-500 (Thymosin Beta-4)
Sequence 15 amino acids (Gly-Glu-Pro-Pro-Pro...)
Molecular Weight โ‰ฅ99% per component (HPLC verified)

Precision research compounds backed by quality, transparency, and consistency.
Research Without Compromise.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Scroll to Top